Moneycontrol PRO
Upcoming Webinar:Watch a panel of experts discuss: Challenges of continuously evolving regulation for Cryptocurrency, on 7th July at 3pm. Register Now
you are here: HomeNewsIndia

Coronavirus wrap August 26 | Phase II human trials of Oxford vaccine begin in Pune; 23 Punjab MLAs test positive

Globally, more than 2.3 crore infections and over 8.1 lakh deaths have been reported due to the COVID-19 pandemic

August 26, 2020 / 08:04 PM IST

India has recorded more than 32.3 lakh COVID-19 cases and 59,449 deaths due to the disease. Of the total cases, 7.07 lakh are active cases, while 24.67 lakh have recovered.

Across the country, 8,23,992 samples were tested for the novel coronavirus on August 25, the Indian Council of Medical Research (ICMR) said.

Maharashtra's COVID-19 tally remains the highest among Indian states and union territories, according to the Union health ministry's latest update.

Tamil Nadu is the second most-affected state, followed by Andhra Pradesh.

The health ministry updates its numbers a day after states release their data.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Globally, more than 2.3 crore infections and over 8.1 lakh deaths have been reported due to the COVID-19 pandemic.

Here are all the latest updates:

>> Ahead of the state assembly session, 23 Punjab MLAs tested positive for COVID-19, the state's Chief Minister Capt. Amarinder Singh said.

>> West Bengal Chief Minister Mamata Banerjee announced that the current lockdown measures in the state will continue till September 20, while a complete lockdown will be observed on September 7, 11 and 12.

>> Former Assam chief minister Tarun Gogoi has been diagnosed with COVID-19. The veteran Congress leader urged all those who came in contact with him recently to get tested.

>> Karnataka said it will be starting the academic year for various degree courses from September 1 with online classes. Offline classes, the state government said, are likely to start in October.

>> Amid strict protocols against the COVID-19 pandemic, a one-day session of the Haryana Assembly began in Chandigarh, with the House paying tributes to 20 Indian soldiers killed in the Galwan Valley clash at the LAC.

>> Phase II human trials of Oxford vaccine began in Pune, with the first dose being administered to two volunteers.

>> A COVID-19 vaccine developed by Australia's University of Queensland showed promising results in animal trials, the varsity said.

>> India's GDP needs to rise annually at 8-8.5 percent to create opportunities in the post-COVID era, and the country risks a decade of stagnating incomes and quality of life if urgent steps are not taken to spur growth, said a report by McKinsey Global Institute.
Moneycontrol News
first published: Aug 26, 2020 08:04 pm
ISO 27001 - BSI Assurance Mark